REFERENCES
- Fallon M, Cherny NI, Hanks G. The management of pain: opioid analgesic therapy. In: Hanks G, Cherny NI, Christakis NA, Fallon M, Kaasa S, Portenoy RK, eds. Oxford Textbook of Palliative Medicine. 4th ed. Oxford University Press UK. Chapter 10.1.6. 2011:661–697.
- World Health Organization. WHO Model Lists of Essential Medicines. 18th edition. Available at: http://www.who.int/medicines/publications/essentialmedicines/en./ Revised October 2013. Accessed February 2, 2014.
- World Health Organization. WHO guidelines for cancer pain and palliative care reach health workers in 31 languages. Available at: http://www.whocancerpain.wisc.edu/?q=node/130. Updated 2002. Accessed February 2, 2014.
- Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2013; 22; 7: CD 003868.
- De la Cruz M, Bruera ED. Opioid side effects and management. In: Bruera ED, Portenoy K, eds. Cancer Pain Assessment and Management. 2nd ed. Chapter 12: Cambridge University Press; 2010:230–254.
- Lopez IA, Ishiyama A, Ishiyama G. Sudden sensorineural hearing loss due to drug abuse. Semin Hear. 2012;33:251–260.
- Christenson BJ, Marjala ARP. Two cases of sudden sensorineural hearing loss after methadone overdose. Ann Pharmacother. 2010;44:207–210.
- Oh AK, Ishiyama A, Baloh RW. Deafness associated with abuse of hydrocodone/acetaminophen. Neurology. 2000;54:2345.
- Tang H, Vrabec J, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain Physician. 2007;10:467–472.